Hand, Foot and Mouth Disease - Pipeline Review, H1 2018

SKU ID :GMD-11927805 | Published Date: 13-Mar-2018 | No. of pages: 39
Table of Contents List of Tables List of Figures Introduction Global Markets Direct Report Coverage Hand, Foot and Mouth Disease - Overview Hand, Foot and Mouth Disease - Therapeutics Development Pipeline Overview Pipeline by Companies Pipeline by Universities/Institutes Products under Development by Companies Products under Development by Universities/Institutes Hand, Foot and Mouth Disease - Therapeutics Assessment Assessment by Target Assessment by Mechanism of Action Assessment by Route of Administration Assessment by Molecule Type Hand, Foot and Mouth Disease - Companies Involved in Therapeutics Development Adimmune Corp Chongqing Zhifei Biological Products Co Ltd CJ HealthCare Corp Sentinext Therapeutics Sdn Bhd Shanghai Zerun Biotechnology Co Ltd Takeda Pharmaceutical Co Ltd Hand, Foot and Mouth Disease - Drug Profiles (coxsackievirus [serotype A16] + enterovirus [serotype 71]) (virus like particle) vaccine - Drug Profile Product Description Mechanism Of Action R&D Progress (coxsackievirus [serotype A16] + enterovirus [serotype 71]) vaccine - Drug Profile Product Description Mechanism Of Action R&D Progress CJ-40010 - Drug Profile Product Description Mechanism Of Action R&D Progress D-5 - Drug Profile Product Description Mechanism Of Action R&D Progress DC-07090 - Drug Profile Product Description Mechanism Of Action R&D Progress E-71 - Drug Profile Product Description Mechanism Of Action R&D Progress Enterovirus [serotype EV-71/C4] vaccine - Drug Profile Product Description Mechanism Of Action R&D Progress Enterovirus [serotype EV-A71] (virus like particle, bivalent) vaccine - Drug Profile Product Description Mechanism Of Action R&D Progress hand, foot and mouth disease (viral like particle, bivalent) vaccine - Drug Profile Product Description Mechanism Of Action R&D Progress Monoclonal Antibody for Hand, Foot and Mouth Disease - Drug Profile Product Description Mechanism Of Action R&D Progress Small Molecules to Inhibit MAP2K1 for Hand, Foot and Mouth Disease - Drug Profile Product Description Mechanism Of Action R&D Progress STX-100 - Drug Profile Product Description Mechanism Of Action R&D Progress TAK-021 - Drug Profile Product Description Mechanism Of Action R&D Progress Hand, Foot and Mouth Disease - Dormant Projects Hand, Foot and Mouth Disease - Product Development Milestones Featured News & Press Releases Mar 11, 2012: Inviragen Reports Top-Line Results From Phase I Trial Of INV21 Vaccine For Treatment Of Hand, Foot And Mouth Disease Appendix Methodology Coverage Secondary Research Primary Research Expert Panel Validation Contact Us Disclaimer
List of Tables Number of Products under Development for Hand, Foot and Mouth Disease, H1 2018 Number of Products under Development by Companies, H1 2018 Number of Products under Development by Universities/Institutes, H1 2018 Products under Development by Companies, H1 2018 Products under Development by Universities/Institutes, H1 2018 Number of Products by Stage and Target, H1 2018 Number of Products by Stage and Mechanism of Action, H1 2018 Number of Products by Stage and Route of Administration, H1 2018 Number of Products by Stage and Molecule Type, H1 2018 Hand, Foot and Mouth Disease - Pipeline by Adimmune Corp, H1 2018 Hand, Foot and Mouth Disease - Pipeline by Chongqing Zhifei Biological Products Co Ltd, H1 2018 Hand, Foot and Mouth Disease - Pipeline by CJ HealthCare Corp, H1 2018 Hand, Foot and Mouth Disease - Pipeline by Sentinext Therapeutics Sdn Bhd, H1 2018 Hand, Foot and Mouth Disease - Pipeline by Shanghai Zerun Biotechnology Co Ltd, H1 2018 Hand, Foot and Mouth Disease - Pipeline by Takeda Pharmaceutical Co Ltd, H1 2018 Hand, Foot and Mouth Disease - Dormant Projects, H1 2018List of Figures Number of Products under Development for Hand, Foot and Mouth Disease, H1 2018 Number of Products under Development by Companies, H1 2018 Number of Products under Development by Universities/Institutes, H1 2018 Number of Products by Targets, H1 2018 Number of Products by Stage and Targets, H1 2018 Number of Products by Mechanism of Actions, H1 2018 Number of Products by Stage and Mechanism of Actions, H1 2018 Number of Products by Molecule Types, H1 2018 Number of Products by Stage and Molecule Types, H1 2018
  • PRICE
  • $2000
    $6000
    Buy Now

Our Clients